Total 0 items
Amount: $0.00

  • Your shopping cart is empty!

  • MaxCal+

MaxCal+

MaxCal+ is the leading brand of next generation of calcium and minerals; it is the best for building your healthy bones. It contains amino acid chelated calcium and trace minerals, vitamin D, and collagen.

  • Highest absorbability and bioavailability, almost 100% soluble and absorbable in the small intestine.
  • Actively absorbed to body through special amino acid absorption channel in the small intestine.
  • No side effects such as constipation, bloating, and gas.
  • Preserves vitamin stability, increases vitamins and trace minerals absorption *
  • Promotes strong bones and teeth *
  • Maintain healthy heart, muscle and nerves *
  • Supports breast and colon health *
  • Helpful for muscle cramps *

    • Calcium Supplement

    * These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Expert Reports on Calcium and Minerals *


    Lyle MacWilliam, MSc

    Lyle MacWilliam, MSc FP is the world famous nutritional expert. In his famous nutritional book, he wrote:

    "Avoid the use of supplements that provide minerals in the form of inorganic mineral salts (such as carbonates, sulphates and phosphates)."*

    "Amino-acid chelated minerals as superior mineral forms…. Beyond their reported superior bioavailability, chelated minerals appear to have lower absorptive interference and better tolerance in the gut than the less expensive mineral salts….they are easily metabolized; non-toxic, helpful in increasing the absorption of the mineral carried "*

    Lyle MacWilliam MSc, Fp "Comparative guide to Nutritional supplements professional Edition, 2007MaxCal+ contains no inorganic minerals.MaxCal+,the best brand of amino acid chelated calcium and trace minerals,is scientifically formulated and developed by Max Biomed Corp.in U.S.A .It contains amino acid chelated calcium, vitamin D,amino acid chelated trace minerals (amino acid chelated zine,amino acid chelated magnesium,amino acid chelated manganese),and collagen.MaxCal+ has FDA Free Sale Certification *

    FOR THE BONE
    "...Adequate calcium and vitamin D intake is crucial to develop optimal peak bone mass and to preserve bone mass throughout life. Supplementation with these 2 nutrients may be necessary in persons not achieving recommended dietary intake"*

    NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy.

    Learn More: http://www.ncbi.nlm.nih.gov/pubmed/11176917?dopt=Abstract

    REDUCE THE FRACTURE
    "...dietary supplementation with calcium and vitamin D moderately reduced bone loss measured in the femoral neck, spine, and total body over the three-year study period and reduced the incidence of nonvertebral fractures..."*
    Dawson-Hughes B, Harris SS, Krall EA, Dallal GE.

    Effect of calcium and vitamin D supplementation on bone density in men and women 65 yearof age or older. N Engl J Med. 1997 Sep 4;337(10):670-6.

    Learn More: http://www.ncbi.nlm.nih.gov/pubmed/9278463?dopt=Abstract

    REDUCE THE CANCER RISK
    "...Improving calcium and vitamin D nutritional status substantially reduces all-cancer risk in postmenopausal women..." *
    Lappe JM, Travers-Gustafson D, Davies KM, et al.

    Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85:1586-91.

    Learn More: http://www.ncbi.nlm.nih.gov/pubmed/17556697?dopt=Abstract

    FOR THE WEIGHT
    "...increasing calcium intake by the equivalent of two dairy servings per day could reduce the risk of overweight substantially, perhaps by as much as 70 percent..." *

    Heaney RP, Davies KM, Barger-Lux MJ. Calcium and weight: clinical studies. J Am Coll Nutr 2002;21:152S-5S.

    Learn More: http://www.ncbi.nlm.nih.gov/pubmed/17556697?dopt=Abstract

    FOR THE GLUCOSE
    "...Vitamin D and calcium insufficiency may negatively influence glycemia, whereas combined supplementation with both nutrients may be beneficial in optimizing glucose metabolism..." *

    Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin d and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-29.

    Learn More: http://www.ncbi.nlm.nih.gov/pubmed/17389701?dopt=Abstract

    FOR THE HYPERTENSION
    "...The pooled estimate shows a statistically significant decrease of systolic blood pressure with calcium supplementation, both for hypertensive persons and for the overall sample..." *

    PAllender PS, Cutler JA, Follmann D, et al. Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Intern Med 1996;124:825-31.

    Learn More: http://www.ncbi.nlm.nih.gov/pubmed/8610952?dopt=Abstract

    FOR THE HEART
    "...Magnesium , when used to supplement other standard rate-reduction therapies, enhances rate reduction and conversion to sinus rhythm in patients with rapid atrial fibrillation..." *

    Davey MJ, Teubner D. A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation. Ann Emerg Med 2005;45:347-53.

    Learn More: http://www.ncbi.nlm.nih.gov/pubmed/15795711?dopt=Abstract

    These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

    Calcium*

    1.   McKevoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
    2. The 2004 Surgeon General's Report on Bone Health and Osteoporosis
    3. Committee on School Health soft drinks in schools. Pediatrics 2004; 113(1Pt 1):152-154
    4. The National Health and Nutrition Examination Survey (NHANES) data on dietary intake of selected minerals 1999-2000.
    5. Fouad, M.T. “Chelation and chelated minerals” J. Appl. Nutr. 28:6
    6. Fang S.M., S.A. Burton and R.V. Peterson, “Bioavailability of zinc: effect of amino acid chelation.” Chelated Mineral Nutrition implants, Animal and Man Charles C. Thomas Publisher, Springfield, IL pp.134-151.
    7. F.M. Clydesdale, Ph.D. “The relevance of mineral chemistry to bioavalability” NUTRITION TODAY March/April 1989
    8. Greger JL and Krashoc Cl. “Effects of a variety of calcium source on mineral metabolism in anemic rats.” Drug Nutr Interact 1988,5(4) 387-94
    9. Kratzer F et al. Chelates in Nutrition. CRC Press, Florida, 1986
    10. Ashmead, HD et al. Intestinal absorption of Metal Ions and Chelates, Charles C. Thomas Publisher, Springfield III. 1985.
    11. Kaemmerer, V.K. et al. “studies with organic and inorganic copper compounds. 1. Oral substitutions of a copper deficiency situation in rats and pigs. Zbl. Vet. Med. 31:645
    12. Scholmerich, J.A. et al. “Bioavailability of zinc from zinc-histidine complexes. 1. Comparison with zinc sulfate in healthy men” Am. J. Clin. Nutr. 45:1480 1987
    13. Snedeker, S.M. et al. “Metabolism of zinc, copper and iron as affected by dietary protein, cysteine and histidine.” J. Nutr. 113:644 1983
    14.  Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670-6.
    15.  Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327:1637-42.
    16.   Chapuy MC, Pamphile R, Paris E, et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002;13:257-64.
    17.  NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-95.
    18.  National Osteoporosis Foundation. Physician's Guide to Prevention and Treatment of Osteoporosis. Universal Recommendations for All Patients. Available at: http://www.nof.org/physguide/univeral_recommendations.htm#adequate. (Accessed 14 May 2005).
    19.  Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 2004;19:370-8.
    20.  Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:2257-64.
    21.  Boonen S, Body JJ, Boutsen Y, et al. Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int 2005;16:239-54.
    22.  Papadimitropoulos E, Wells G, Shea B, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 2002;23:560-9.
    23.   McGarry KA, Kiel DP. Postmenopausal osteoporosis. Strategies for preventing bone loss, avoiding fracture. Postgrad Med 2000;108:79-82,85-88, 91.
    24.  Bryant RJ, Cadogan J, Weaver CM. The new dietary reference intakes for calcium: implications for osteoporosis. J Am Coll Nutr 1999;18:406S-412S.
    25.   Nieves JW, Komar L, Cosman F, Lindsay R. Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis. Am J Clin Nutr 1998;67:18-24.
    26.  Kanis JA. The use of calcium in the management of osteoporosis. Bone 1999;24:279-90.
    27.  Storm D, Eslin R, Porter ES, et al. Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized, placebo-controlled trial. J Clin Endocrinol Metab 1998;83:3817-25.
    28.  Riggs BL, O'Fallon WM, Muhs J, et al. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res 1998;13:168-74.
    29.  Devine A, Dick IM, Heal SJ, et al. A 4-year follow-up study of the effects of calcium supplementation on bone density in elderly postmenopausal women. Osteoporos Int 1997;7:23-8.
    30.  Heaney RP. Calcium, dairy products and osteoporosis. J Am Coll Nutr 2000;19:83S-99S.
    31.   Deal C. Can calcium and vitamin D supplementation adequately treat most patients with osteoporosis? Cleve Clin J Med 2000;67:696-8.
    32.  Castelo-Branco C, Pons F, Vicente JJ, et al. Preventing postmenopausal bone loss with ossein-hydroxyapatite compounds. Results of a two-year, prospective trial. J Reprod Med 1999;44:601-5.
    33.   Chiu KM. Efficacy of calcium supplements on bone mass in postmenopausal women. J Gerontol A Biol Sci Med Sci 1999;54:M275-80.
    33.  Heaney RP, Rafferty K. Carbonated beverages and urinary calcium excretion. Am J Clin Nutr 2001;74:343-7. 31.  Deal C. Can calcium and vitamin D supplementation adequately treat most patients with osteoporosis? Cleve Clin J Med 2000;67:696-8.
    34.  Liu S, Song Y, Ford ES, et al. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 2005;28:2926-32.
    35.  Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin d and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-29.
    36.   Shils M, Olson A, Shike M. Modern Nutrition in Health and Disease. 8th ed. Philadelphia, PA: Lea and Febiger, 1994.
    37.   Whelton PK, Kumanyika SK, Cook NR, et al. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the trials of hypertension prevention (TOHP). Trials of Hypertension Prev (TOHP) Collab Res Group. Am J Clin Nutr 1997;65:652S-60S.
    38.  Yamamoto ME, Applegate WB. Klag MJ, et al. Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from phase I of the trials of hypertension prevention (TOHP). Trials of Hypertension Prev (TOHP) Collab Res Group. Ann Epidemiol 1995;5:96-107.
    39.  Weinberger MH, Wagner UL, Fineberg NS. The blood pressure effects of calcium supplementation in humans of known sodium responsiveness. Am J Hypertens 1993;6:799-805.
    40.   Dwyer JH, Dwyer KM, Scribner RA, et al. Dietary calcium, calcium supplementation, and blood pressure in African American adolescents. Am J Clin Nutr 1998;68:648-55.
    41.  Allender PS, Cutler JA, Follmann D, et al. Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Intern Med 1996;124:825-31.
    42.  Bucher HC, Cook RJ, Guyatt GH, et al. Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials. JAMA 1996;275:1016-22.
    43.  Kawano Y, Yoshimi H, Matsuoka H, et al. Calcium supplementation in patients with essential hypertension: assessment by office, home and ambulatory blood pressure. J Hypertens 1998;16:1693-9.
    44.  Griffith LE, Guyatt GH, Cook RJ, et al. The influence of dietary and nondietary calcium supplementation on blood pressure: an updated meta-analysis of randomized controlled trials. Am J Hypertens 1999;12:84-92.
    45.  Jorde R, Bonaa KH. Calcium from dairy products, vitamin D intake, and blood pressure: the Tromso study. Am J Clin Nutr 2000;71:1530-5.
    http://books.nap.edu/books/0309063507/html/index.html.
    46.  Reid IR, Horne A, Mason B, Ames R, Bava U, Gamble GD. Effects of calcium supplementation on body weight and blood pressure in normal older women: A Randomized Controlled Trial. J Clin Endocrinol Metab 2005;90:3824-9.
    47.  van Mierlo LA, Arends LR, Streppel MT, et al. Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens 2006;20:571-80.
    48.   Petersen LJ, Rudnicki M, Hojsted J. Long-term oral calcium supplementation reduces diastolic blood pressure in end stage renal disease. A randomized, double-blind, placebo-controlled study. Int J Artif Organs 1994;17:37-40.
    49.   Lin J, Manson JE, Lee IM, et al. Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med 2007;167:1050-9.
    50.  Heaney RP, Davies KM, Barger-Lux MJ. Calcium and weight: clinical studies. J Am Coll Nutr 2002;21:152S-5S.
    51.  Buchowski MS, Semenya J, Johnson AO. Dietary calcium intake in lactose maldigesting intolerant and tolerant African-American women. J Am Coll Nutr 2002;21:47-54.
    52.  Tanasescu M, Ferris AM, Himmelgreen DA, et al. Biobehavioral factors are associated with obesity in Puerto Rican children. J Nutr 2000;130:1734–42.
    53.  Jacqmain M, Doucet E, Després JP, et al. Calcium intake, body composition, and lipoprotein-lipid concentrations in adults. Am J Clin Nutr 2003;77:1448–52.
    54.  Davies KM, Heaney RP, Recker RR, et al. Calcium intake and body weight. J Clin Endocrinol Metab 2000;85:4635-8.
    55.  Lorenzen JK, Molgaard C, Michaelsen KF, Astrup A. Calcium supplementation for 1 y does not reduce body weight or fat mass in young girls. Am J Clin Nutr 2006;83:18-23.
    56.  Bell L, Halstenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med 1992;152:2441-4.
    57.  Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85:1586-91.
    58.  Bendich A. The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms. J Am Coll Nutrition 2000;19:3-12.
    59.  Thys-Jacobs S, Starkey P, Bernstein D, Tian J. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol 1998;179:444-52.
    60.  Alvir JM, Thys-Jacobs S. Premenstrual and menstrual symptom clusters and response to calcium treatment. Psychopharmacol Bull 1991;27:145-8.
    61.  Thys-Jacobs S, Ceccarelli S, Bierman A, et al. Calcium supplementation in premenstrual syndrome: a randomized crossover trial. J Gen Intern Med 1989;4:183-9.
    62.  Iso H, Stampfer MJ, Manson JE, et al. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke 1999;30:1772-9.
    63.  Baron JA, Beach M, Wallace K, et al. Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev 2005;14:586-9.
    64.  Koo WK, Walters JC, Esterlitz J, et al. Maternal calcium supplementation and fetal bone mineralization. Obstet Gynecol 1999;94:577-82.
    65.  Raman L, Rajalakshmi K, Krishnamachari KAVR, et al. Effect of calcium supplementation to undernourished mothers during pregnancy on the bone density of the neonates. Am J Clin Nutr 1978; 31:466-9.
    66.   Bernstein CN, Seeger LL, Anton PA, et al. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther 1996;10:777-86.
    67.  Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized double-blind, placebo-controlled trial. Ann Intern Med 1996;125:961-8.
    68.  Adachi JD, Ioannidis G. Calcium and vitamin D therapy in corticosteroid-induced bone loss: what is the evidence? Calcif Tissue Int 1999;65:332-6.
    69.  Adachi JD, Bensen WG, Bianchi F, et al. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup. J Rheumatol 1996;23:995-1000.
    70.  Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines. Arthritis Rheum 1996;39:1791-801.
    71.  Lems WF, Van Veen GJ, Gerrits MI, et al. Effect of low-dose prednisolone (with calcium and calcitriol supplementation) on calcium and bone metabolism in healthy volunteers. Br J Rheumatol 1998;37:27-33.
    72.  Reid DM, Kennedy NS, Smith MA, et al. Total body calcium in rheumatoid arthritis: Effects of disease activity and corticosteroid treatment. Br Med J (Clin Res Ed) 1982;285:330-2.
    73.  Lems WF, Jacobs JW, Netelenbos JC, et al. [Pharmacological prevention of osteoporosis in patients on corticosteroid medication]. [Article in Dutch]. Ned Tijdschr Geneeskd 1998;142:1904-8.
    74.   Gennari C. Differential effect of glucocorticoids on calcium absorption and bone mass. Br J Rheumatol 1993;32:11-4.
    75.  Need AG, Philcox JC, Hartley TF, et al. Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women. Aust N Z J Med 1986;16:341-6.
    76.  Reid IR, Ibbertson HK. Calcium supplements in the prevention of steroid-induced osteoporosis. Am J Clin Nutr 1986;44:287-90.
    77.  Homik J, Suarez-Almazor ME, Shea B, et al. Calcium and vitamin D for corticosteroid-induced osteoporosis. Cochrane Database Syst Rev 2000;(2):CD000952.
    78.  White E, Shannon JS, Patterson RE. Relationship between vitamin and calcium supplement use and colon cancer. Cancer Epidemiol Biomarkers Prev 1997;6:769-74.
    79.  Terry P, Baron JA, Bergkvist L, et al. Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in women. Nutr Cancer 2002;43:39-46.
    80.  Cho E, Smith-Warner SA, Spiegelman D, et al. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst 2004;96:1015-22.
    81.   Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prev Study Group. N Engl J Med 1999;340:101-7.
    82.  Grau MV, Baron JA, Sandler RS, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003;95:1765-71.
    83.  Weingarten MA, Zalmanovici A, Yaphe J. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. Cochrane Database Syst Rev 2004;(1):CD003548.
    84.  Grau MV, Baron JA, Sandler RS, et al. Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst 2007;99:129-36.
    85.  Krall EA, Wehler C, Garcia RI, et al. Calcium and vitamin D supplements reduce tooth loss in the elderly. Am J Med 2001;111:452-6.
    86.   Hammar M, Larsson L, Tegler L. Calcium treatment of leg cramps in pregnancy. Effect on clinical symptoms and total serum and ionized serum calcium concentrations. Acta Obstet Gynecol Scand 1981;60:345-7.


    Vitamin D*

    87.  Minne HW, Pfeifer M, Begerow B, et al. Vitamin D and calcium supplementation reduces falls in elderly women via improvement of body sway and normalization of blood pressure: a prospective, randomized, and double-blind study. Abstracts World Congress on Osteoporosis 2000.
    88.  Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of Vitamin D on falls: a meta-analysis. JAMA 2004;291:1999-2006.
    89.  Flicker L, Mead K, MacInnis RJ, et al. Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc 2003;51:1533-8.
    90.  Dhesi JK, Moniz C, Close JC, et al. A rationale for vitamin D prescribing in a falls clinic population. Age Ageing 2002;31:267-71.
    91.   Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003;18:343-51.
    92.  Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B. Effect of Cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med 2006;166:424-30.
    93.  Broe KE, Chen TC, Weinberg J, et al. A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007;55:234-9.
    94.  Prince RL, Austin N, Devine A, et al. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med 2008;168:103-8.
    95.  Urashima M, Segawa T, Okazaki M, et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010;91:1255-60.
    96.  Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117;503-11.
    97.  Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States. Arch Intern Med 2007;167:1159-65.
    98.  Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1730-7.
    99.   Merlino LA, Curtis J, Mikuls TR, et al. Vitamin D intake is inversely associated with rheumatoid arthritis. Arthritis Rheum 2004;50:72-7.
    100.  Bertone-Johnson ER, Hankinson SE, Bendich A, et al. Calcium and vitamin D intake and risk of incident premenstrual syndrome. Arch Intern Med 2005;165:1246-52.
    101.  Khajehei M, Abdali K, Parsanezhad ME, Tabatabaee HR. Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome. Int J Gynaecol Obstet 2009;105:158-61.
    102.  Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press, 1999. Available at:


    Trace Minerals: Magnesium, Zinc, Manganese**

    103.   Stendig-Lindberg G, Tepper R, Leichter I. Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis. Magnes Res 1993;6:155-63.
    104.   Tucker KL, Hannan MT, Chen H, et al. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr 1999;69:727-36.
    105.   Houtkooper LB, Ritenbaugh C, Aickin M, et al. Nutrients, body composition and exercise are related to change in bone mineral density in premenopausal women. J Nutr 1995;125:1229-37.
    106.   New SA, Bolton-Smith C, Grubb DA, Reid DM. Nutritional influences on bone mineral density: a cross-sectional study in premenopausal women. Am J Clin Nutr 1997;65:1831-9.
    107.   Tranquilli AL, Lucino E, Garzetti GG, Romanini C. Calcium, phosphorus and magnesium intakes correlate with bone mineral content in postmenopausal women. Gynecol Endocrinol 1994;8:55-8.
    108.   Strause L, Saltman P, Smith KT, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr 1994;124:1060-4.

    109.  Lasserre B, Spoerri M, Moullet V, et al. Should magnesium therapy be considered for the treatment of coronary heart disease? II. Epidemiological evidence in outpatients with and without coronary heart disease. Magnes Res 1994;7:145-53.
    110.   Meyer KA, Kushi LH, Jacobs DR, et al. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 2000;71:921-30.
    111.  Song Y, Manson JE, Buring JE, Liu S. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 2004;27:59-65
    112.  Fung TT, Manson JE, Solomon CG, et al. The association between magnesium intake and fasting insulin concentration in healthy middle-aged women. J Am Coll Nutr 2003;22:533-8.
    113.   Lopez-Ridaura R, Willett WC, Rimm EB, et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 2004;27:134-40.
    114.   Huerta MG, Roemmich JN, Kington ML, et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care 2005;28:1175-81.
    115.   Mossad SB, Macknin ML, Medendorp SV, Mason P. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann Intern Med 1996;125:81-8.
    116.   Godfrey JC, Conant Sloane B, Smith DS, et al. Zinc gluconate and the common cold: a controlled clinical study. J Int Med Res 1992;20:234-6.
    117.  Al-Nakib W, Higgins PG, Barrow I, et al. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother 1987;20:893-901.
    118.  Farr BM, Conner EM, Betts RF, et al. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother 1987;31:1183-7.
    119.  Prasad AS, Fitzgerald JT, Bao B, et al. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000;133:245-52.
    120.  Petrus EJ, Lawson KA, Bucci LR, Blum K. Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects. Curr Ther Res 1998;59:595-607.
    121.   Dreno B, Trossaert M, Boiteau HL, Litoux P. Zinc salts effects on granulocyte zinc concentration and chemotaxis in acne patients. Acta Derm Venereol 1992;72:250-2.
    122.  Amer M, Bahgat MR, Tosson Z, et al. Serum zinc in acne vulgaris. Int J Dermatol 1982;21:481-4.
    123.  Michaelsson G, Vahlquist A, Juhlin L. Serum zinc and retinol-binding protein in acne. Br J Dermatol 1977;96:283-6.
    124.  Michaelsson G, Ljunghall K. Patients with dermatitis herpetiformis, acne, psoriasis and Darier's disease have low epidermal zinc concentrations. Acta Derm Venereol 1990;70:304-8.
    125.  Goransson K, Liden S, Odsell L. Oral zinc in acne vulgaris: a clinical and methodological study. Acta Derm Venereol 1978;58:443-8.
    126.  Hillstrom L, Pettersson L, Hellbe L, et al. Comparison of oral treatment with zinc sulphate and placebo in acne vulgaris. Br J Dermatol 1977;97:681-4.
    127.  Meynadier J. Efficacy and safety study of two zinc gluconate regimens in the treatment of inflammatory acne. Eur J Dermatol 2000 May;10:269-73
    128.  Michaelsson G, Juhlin L, Vahlquist A. Effects of oral zinc and vitamin A in acne. Arch Dermatol 1977;113:31-6.
    129.   Dreno B, Amblard P, Agache P, et al. Low doses of zinc gluconate for inflammatory acne. Acta Derm Venereol 1989;69:541-3.
    130.   Orris L, Shalita AR, Sibulkin D, et al. Oral zinc therapy of acne. Absorption and clinical effect. Arch Dermatol 1978;114:1018-20.
    131.  Weismann K, Wadskov S, Sondergaard J. Oral zinc sulphate therapy for acne vulgaris. Acta Derm Venereol 1977;57:357-60.
    132.  Rodriguez de la Serna A, Diaz-Rubio M. Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenteropathy. Spanish Study Group on NSAID Induced Gastroenteropathy Prevention. J Rheumatol 1994;21:927-33.
    133.  Jimenez E, Bosch F, Galmes JL, Banos JE. Meta-analysis of efficacy of zinc acexamate in peptic ulcer. Digestion 1992;51:18-26.
    *  Some information from Jellin JM, Gregory PJ, et al. Pharmacist’s letter/Prescriber’s Letter Natural Medicines Comprehensive Database. 12th ed. Stockton, CA: Therapeutic Research Faculty; 2009

    1.     What are the health benefits of taking MaxCal+?

     

    The nutrients in MaxCal+ may promote strong bones and teeth; maintain healthy heart, muscle and nerves; support breast and colon health. It is also very helpful for muscle cramps.*

     

     

    2.     Is it safe to take MaxCal+?

     

    Yes, it is very safe to take MaxCal+. All the ingredients in MaxCal+ are pure nature nutrients. MaxCal+ is made at FDA certified GMP standard manufacturer in USA. MaxCal+ also has FDA Free Sale Certificate.*

     

    3.     Is it best to take the MaxCal+ with meal?

     

    Yes, it is best to take MaxCal+ with meal. The food in your stomach will significantly improve the absorption of the nutrients in MaxCal+ capsules.

     

    4.     How many MaxCal+ capsules should I take a day?

     

    For adult, take 2 capsules with meal, 1-2 times a day.

     

    5.     Can I take at night time?

     

    Yes, you can take at night time. Actually, take MaxCal+ at night may improve the absorption of the nutrients in MaxCal+ capsules.

     

     

    * These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

    Write a review

    Note: HTML is not translated!
        Bad           Good

    MaxCal+

    • Product Code: A001
    • Availability: In Stock

    • $31.99


    0 reviews / Write a review